KRAS and myeloproliferative neoplasm: Conditional Kras A146T expression in HSC (Mx1-Cre) lead to myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) with the expansion of immature myeloid cells in the BM and spleen.